Icatibant

被引:36
作者
Bork, Konrad [1 ]
Yasothan, Uma [2 ]
Kirkpatrick, Peter
机构
[1] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Haut Klin, D-55131 Mainz, Germany
[2] IMS Hlth, London NW1 6JB, England
关键词
D O I
10.1038/nrd2694
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:801 / 802
页数:2
相关论文
共 15 条
[1]   Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema [J].
Bork, K ;
Meng, G ;
Staubach, P ;
Hardt, J .
TRANSFUSION, 2005, 45 (11) :1774-1784
[2]   Hereditary angioedema with normal C1 inhibitor:: Clinical symptoms and course [J].
Bork, Konrad ;
Guel, Dondu ;
Hardt, Jochen ;
Dewald, Georg .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (11) :987-992
[3]   Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant) [J].
Bork, Konrad ;
Frank, Jorge ;
Grundt, Boris ;
Schlattmann, Peter ;
Nussberger, Juerg ;
Kreuz, Wolfhart .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (06) :1497-1503
[4]   Recombinant human C1-inhibitor in the treatment of acute angioedema attacks [J].
Choi, Goda ;
Soeters, Maarten R. ;
Farkas, Henriette ;
Varga, Lilian ;
Obtulowicz, Krystyna ;
Bilo, Barbara ;
Porebski, Greg ;
Hack, C. Erik ;
Verdonk, Rene ;
Nuijens, Jan ;
Levi, Marcel .
TRANSFUSION, 2007, 47 (06) :1028-1032
[5]   New treatments addressing the pathophysiology of hereditary angioedema [J].
Davis III A.E. .
Clinical and Molecular Allergy, 6 (1)
[6]  
*EMEA, 2008, EMEA WEB SIT
[7]   C1 inhibitor deficiency: consensus document [J].
Gompels, MM ;
Lock, RJ ;
Abinun, M ;
Bethune, CA ;
Davies, G ;
Grattan, C ;
Fay, AC ;
Longhurst, HJ ;
Morrison, L ;
Price, A ;
Price, M ;
Watters, D .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03) :379-394
[8]  
HILLIKER I, 2008, JERINI
[9]  
HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x
[10]   Bradykinin receptor ligands: Therapeutic perspectives [J].
Marceau, F ;
Regoli, D .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (10) :845-852